메뉴 건너뛰기




Volumn 21, Issue 4, 2008, Pages 827-832

No association of the NF-κB1 -94ins/DELATTG promoter polymorphism with relapse-free and overall survival in patients with squamous cell carcinomas of the head and neck region

Author keywords

94ins delATTG; HNSCC; NFKB1; Polymorphism; Prognostic marker

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

EID: 59849096359     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200802100407     Document Type: Article
Times cited : (14)

References (23)
  • 1
    • 0035137882 scopus 로고    scopus 로고
    • Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB
    • Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 2001; 107:241-6.
    • (2001) J Clin Invest , vol.107 , pp. 241-246
    • Baldwin, A.S.1
  • 2
    • 3242687235 scopus 로고    scopus 로고
    • Inducible nuclear factor-kappaB activation contributes to chemotherapy resistance in gastric cancer
    • Camp ER, Li J, Minnich DJ, et al. Inducible nuclear factor-kappaB activation contributes to chemotherapy resistance in gastric cancer. J Am Coll Surg 2004; 199:249-58.
    • (2004) J Am Coll Surg , vol.199 , pp. 249-258
    • Camp, E.R.1    Li, J.2    Minnich, D.J.3
  • 3
    • 1542644825 scopus 로고    scopus 로고
    • NF-kappaB in mammary gland development and breast cancer
    • Cao Y, Karin M. NF-kappaB in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 2003; 8:215-23.
    • (2003) J Mammary Gland Biol Neoplasia , vol.8 , pp. 215-223
    • Cao, Y.1    Karin, M.2
  • 4
    • 0037421484 scopus 로고    scopus 로고
    • NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia
    • Dajee M, Lazarov M, Zhang JY, et al. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 2003; 421:639-43.
    • (2003) Nature , vol.421 , pp. 639-643
    • Dajee, M.1    Lazarov, M.2    Zhang, J.Y.3
  • 5
    • 16344373565 scopus 로고    scopus 로고
    • Gene transfer of inhibitor kappaB in human lung cancer cell line NCI-H460 inhibits tamorigenesis and angiogenesis in vivo
    • Ni J, Takayama K, Inoshima N, et al. Gene transfer of inhibitor kappaB in human lung cancer cell line NCI-H460 inhibits tamorigenesis and angiogenesis in vivo. Anticancer Res 2005; 25:69-77.
    • (2005) Anticancer Res , vol.25 , pp. 69-77
    • Ni, J.1    Takayama, K.2    Inoshima, N.3
  • 6
    • 34547837548 scopus 로고    scopus 로고
    • Insertion/deletion polymorphism in the promoter of NFKB1 as a potential molecular marker for the risk of recurrence in superficial bladder cancer
    • Riemann K, Becker L, Struwe H, Rubben H, Eisenhardt A, Siffert W. Insertion/deletion polymorphism in the promoter of NFKB1 as a potential molecular marker for the risk of recurrence in superficial bladder cancer. Int J Clin Pharmacol Ther 2007; 45:423-30.
    • (2007) Int J Clin Pharmacol Ther , vol.45 , pp. 423-430
    • Riemann, K.1    Becker, L.2    Struwe, H.3    Rubben, H.4    Eisenhardt, A.5    Siffert, W.6
  • 7
    • 24344452099 scopus 로고    scopus 로고
    • NF-kappaB activation contributes to anthracycline resistance pathway in human ovarian carcinoma cell line A2780
    • Salvatore C, Camarda G, Maggi CA, Goso C, Manzini S, Binaschi M. NF-kappaB activation contributes to anthracycline resistance pathway in human ovarian carcinoma cell line A2780. Int J Oncol 2005; 27:799-806.
    • (2005) Int J Oncol , vol.27 , pp. 799-806
    • Salvatore, C.1    Camarda, G.2    Maggi, C.A.3    Goso, C.4    Manzini, S.5    Binaschi, M.6
  • 8
    • 19944405795 scopus 로고    scopus 로고
    • Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively
    • Tracey L, Perez-Rosado A, Artiga MJ, et al. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively. J Pathol 2005; 206:123-34.
    • (2005) J Pathol , vol.206 , pp. 123-134
    • Tracey, L.1    Perez-Rosado, A.2    Artiga, M.J.3
  • 9
    • 34447129731 scopus 로고    scopus 로고
    • Insertion/deletion polymorphism in the promoter of NFKB1 influences severity but not mortality of acute respiratory distress syndrome
    • Adamzik M, Frey UH, Rieman K, et al. Insertion/deletion polymorphism in the promoter of NFKB1 influences severity but not mortality of acute respiratory distress syndrome. Intensive Care Med 2007; 33:1199-203.
    • (2007) Intensive Care Med , vol.33 , pp. 1199-1203
    • Adamzik, M.1    Frey, U.H.2    Rieman, K.3
  • 10
    • 0347917295 scopus 로고    scopus 로고
    • Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis
    • Karban AS, Okazaki T, Panhuysen CI, et al. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 2004; 13:35-45.
    • (2004) Hum Mol Genet , vol.13 , pp. 35-45
    • Karban, A.S.1    Okazaki, T.2    Panhuysen, C.I.3
  • 11
    • 33749444114 scopus 로고    scopus 로고
    • Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers
    • Lin SC, Liu CJ, Yeh WI, Lui MT, Chang KW, Chang CS. Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. Cancer Lett 2006; 243:47-54.
    • (2006) Cancer Lett , vol.243 , pp. 47-54
    • Lin, S.C.1    Liu, C.J.2    Yeh, W.I.3    Lui, M.T.4    Chang, K.W.5    Chang, C.S.6
  • 12
    • 33750375793 scopus 로고    scopus 로고
    • No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia
    • Riemann K, Becker L, Struwe H, et al. No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia. Pharmacogenet Genomics 2006; 16:783-8.
    • (2006) Pharmacogenet Genomics , vol.16 , pp. 783-788
    • Riemann, K.1    Becker, L.2    Struwe, H.3
  • 13
    • 59849112804 scopus 로고    scopus 로고
    • Gauderman WJ, Morrison JM. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies. http://hydra.usc.edu/gxe 2006.
    • Gauderman WJ, Morrison JM. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies. http://hydra.usc.edu/gxe 2006.
  • 14
    • 0036546501 scopus 로고    scopus 로고
    • NF-kappaB in cancer: From innocent bystander to major culprit
    • Karin M, Cao Y, Greten FR, Li ZW. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002; 2:301-10.
    • (2002) Nat Rev Cancer , vol.2 , pp. 301-310
    • Karin, M.1    Cao, Y.2    Greten, F.R.3    Li, Z.W.4
  • 15
    • 23244466456 scopus 로고    scopus 로고
    • Areca (betel) nut extract activates mitogen-activated protein kinases and NF-kappaB in oral keratinocytes
    • Lin SC, Lu SY, Lee SY, Lin CY, Chen CH, Chang KW. Areca (betel) nut extract activates mitogen-activated protein kinases and NF-kappaB in oral keratinocytes. Int J Cancer 2005; 116:526-35.
    • (2005) Int J Cancer , vol.116 , pp. 526-535
    • Lin, S.C.1    Lu, S.Y.2    Lee, S.Y.3    Lin, C.Y.4    Chen, C.H.5    Chang, K.W.6
  • 16
    • 0036710479 scopus 로고    scopus 로고
    • Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit
    • Vermeulen L, De WG, Notebaert S, Vanden BW, Haegeman G. Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit. Biochem Pharmacol 2002; 64:963-70.
    • (2002) Biochem Pharmacol , vol.64 , pp. 963-970
    • Vermeulen, L.1    De, W.G.2    Notebaert, S.3    Vanden, B.W.4    Haegeman, G.5
  • 17
    • 0036709174 scopus 로고    scopus 로고
    • Nuclear factor-kappa B and cancer: Its role in prevention and therapy
    • Bharti AC, Aggarwal BB. Nuclear factor-kappa B and cancer: its role in prevention and therapy. Biochem Pharmacol 2002; 64:883-8.
    • (2002) Biochem Pharmacol , vol.64 , pp. 883-888
    • Bharti, A.C.1    Aggarwal, B.B.2
  • 18
    • 0032885434 scopus 로고    scopus 로고
    • Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines
    • Ondrey FG, Dong G, Sunwoo J, et al. Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines. Mol Carcinog 1999; 26:119-29.
    • (1999) Mol Carcinog , vol.26 , pp. 119-129
    • Ondrey, F.G.1    Dong, G.2    Sunwoo, J.3
  • 19
    • 0033105360 scopus 로고    scopus 로고
    • Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck
    • Chan G, Boyle JO, Yang EK, et al. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 1999; 59:991-4.
    • (1999) Cancer Res , vol.59 , pp. 991-994
    • Chan, G.1    Boyle, J.O.2    Yang, E.K.3
  • 21
    • 33750884111 scopus 로고    scopus 로고
    • NF-kappaB and COX-2 during oral tumorigenesis and in assessment of minimal residual disease in surgical margins
    • Santhi WS, Sebastian P, Varghese BT, Prakash O, Pillai MR. NF-kappaB and COX-2 during oral tumorigenesis and in assessment of minimal residual disease in surgical margins. Exp Mol Pathol 2006; 81:123-30.
    • (2006) Exp Mol Pathol , vol.81 , pp. 123-130
    • Santhi, W.S.1    Sebastian, P.2    Varghese, B.T.3    Prakash, O.4    Pillai, M.R.5
  • 22
    • 0034892532 scopus 로고    scopus 로고
    • Inflammation, carcinogenesis and cancer
    • Fitzpatrick FA. Inflammation, carcinogenesis and cancer. Int Immunopharmacol 2001; 1:1651-67.
    • (2001) Int Immunopharmacol , vol.1 , pp. 1651-1667
    • Fitzpatrick, F.A.1
  • 23
    • 0032702856 scopus 로고    scopus 로고
    • A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells
    • Nishimura G, Yanoma S, Mizuno H, Kawakami K, Tsukuda M. A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells. Jpn J Cancer Res 1999; 90:1152-62.
    • (1999) Jpn J Cancer Res , vol.90 , pp. 1152-1162
    • Nishimura, G.1    Yanoma, S.2    Mizuno, H.3    Kawakami, K.4    Tsukuda, M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.